In the rat, estrone sulphate is the main serum metabolite of oral oleoyl-estrone

Journal of Endocrinological Investigation

Volumn 30, Issue 5, 2007, Pages 376-381

  Cabot, C ^a   Gonzalez Martinez D ^a   Fernandez Lopez J A ^a   Alemany, M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Acyl estrone; Estradiol; Estrone; Estrone sulphate; Oleoyl estrone

Indexed keywords

ACYL ESTRONE; DRUG METABOLITE; ESTRADIOL; ESTROGEN; ESTRONE; ESTRONE OLEATE; ESTRONE SULFATE; SEX HORMONE; UNCLASSIFIED DRUG; ANTIOBESITY AGENT; DRUG DERIVATIVE; OLEIC ACID; OLEOYL-ESTRONE;

ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DOSE COMPARISON; DRUG METABOLISM; FEEDING; HORMONE BLOOD LEVEL; MALE; NONHUMAN; RAT; WISTAR RAT; ANIMAL; BLOOD; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANIMALS; ANTI-OBESITY AGENTS; ESTRADIOL; ESTRONE; MALE; OLEIC ACIDS; RATS; RATS, WISTAR;

EID: 34247845030     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03346313     Document Type: Article

References (23)

1. Sanchis D, Balada F, del Mar Grasa M, et al. Oleoyl-estrone induces the loss of body fat in rats. Int J Obes Relat Metab Disord 1996, 20: 588-94.
2. Esteve M, Savall P, Blay MT, Fernández-López JA, Remesar X, Alemany M. Intestinal handling of an oral oleoyl-estrone gavage by the rat. Life Sci 2001, 69: 763-77.
3. Ferrer-Lorente R, García-Peláez B, Gómez-Ollés S, Fernández-López JA, Remesar X, Alemany M. Effects of oral estrone on rat energy balance. Steroids 2005, 70: 667-72.
4. Grasa MM, Cabot C, Esteve M, et al. Daily oral oleoyl-estrone gavage induces a dose-dependent loss of fat in Wistar rats. Obes Res 2001, 9: 202-9.
5. Remesar X, Tang V, Ferrer E, et al. Estrone in food: a factor influencing the development of obesity? Eur J Nutr 1999, 38: 247-53.
6. García-Peláez B, Ferrer-Lorente R, Gómez-Ollés S, Fernández-López JA, Remesar X, Alemany M. Technical note: Measurement of total estrone content in foods. Application to dairy products. J Dairy Sci 2004, 87: 2331-6.
7. Andersson S, Moghrabi N. Physiology and molecular genetics of 17β-hydroxysteroid dehydrogenases. Steroids 1997, 62: 143-7.
8. Labrie F, Luu-The V, Lin SX, Labrie C, Simard J, Breton R, Bélanger A. The key role of 17β-hydroxysteroid dehydrogenases in sex steroid biology. Steroids 1997, 62: 148-58.
9. Cabot C, Grasa MM, Massanés RM, et al. Oleoyl-estrone does not have direct estrogenic effects on rats. Life Sci 2001, 69: 749-61.
10. Alemany M, Fernández-López JA, Petrobelli A, Granada M, Foz M, Remesar X. Pérdida de peso en un paciente con obesiclad mórbida en tratarniento con oleoil-estrona. Med Clin (Barc) 2003, 121: 496-9.
11. Massanés RM, Grasa MM, López-Martí, et al. Zucker obese rats store less acyl-estrone than lean controls. Int J Obes Relat Metab Disord 2003, 27: 428-32.
12. Remesar X, Guijarro P, Torregrosa C, et al. Oral oleoyl-estrone induces the rapid loss of body fat in Zucker lean rats fed a hyperlipidic diet. Int J Obes Relat Metab Disord 2000, 24: 1405-12.
13. Ardévol A, Virgili J, Sanchis D, Adán C, et al. A method for the measurement of plasma estrone fatty ester levels. Anal Biochem 1997, 249: 247-50.
14. Cabot C, Salas A, Ferrer-Lorente R, et al. Short-term oral oleoyl-estrone treatment increases plasma cholesterol turnover in the rat. Int J Obes (Lond) 2005, 29: 534-9.
15. Peltoketo H, Vihko P, Vihko R. Regulation of estrogen action: role of 17β-hydroxysteroid dehydrogenases. Vitam Horm 1999, 55: 353-98.
16. Ferrer-Lorente R, García Peláez B, Fernández-López JA, Remesar X, Alemany M. Tamoxifen does not Prevent the mobilization of body lipids elicited by oleoyl-estrone. Steroids 2004, 69: 661-5.
17. van den Belt K, Berckmans P, Vangenechten C, Verheyen R, Witters H. Comparative study on the in vitro/in vivo estrogenic potencies of 17 beta-estradiol, estrone, 17 alpha-ethynylestradiol and nonylphenol. Aquat Toxicol 2004, 66: 183-95.
18. Li W, Seifert M, Xu Y, Hock B. Comparative study of estrogenic potencies of estradiol, tamoxifen, bisphenol-A and resveratrol with two in vitro bioassays. Environ Int 2004, 30: 329-35.
19. Hernández JS, Watson RWG, Wood TC, Weinshilboum RM. Sulfation of estrone and 17β-estradiol in human liver. Catalysis by thermostable phenol sulfctransferase and by dehydroepiandrosterone sulfotransferase. Drug Metab Dispos 1992, 20: 413-22.
20. Longcope C. The metabolism of estrone sulfate in normal males. J Clin Endocrinol 1972, 34: 113-22.
21. Adlercreutz H, Gorbach SL, Goldin BR, Woods MN, Dwyer JT, Hämäläinen E. Estrogen metabolism and excretion in Oriental and Caucasian women. J Natl Cancer Inst 1994, 86: 1076-82.
22. Zhu BT, Bui QD, Weisz J, Liehr JG. Conversion of estrone to 2- and 4-hydroxyestrone by hamster kidney and liver microsomes: implications forthe mechanism of estrogen-induced carcinogenesis. Endocrinology 1994, 135: 1772-9.
23. Lee AJ, Cai MX, Thomas PE, Conney AH, Zhu BT Characterization of the oxidative metabolites of 17 beta-estradiol and estrone formed by 15 selectively expressed human cytochrome P450 isoforms. Endocrinology 2003, 144: 3382-98.